Gossamer Bio, Inc. · GETTEX:4GB

Gossamer Bio, Inc. financial statements

Gossamer Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue48.5M114.7M00000000
Cost of revenue1.00M4.15M4.38M4.43M5.17M4.27M3.09M297.0K00
Gross profit47.5M114.7M-4.38M-4.43M-5.17M-4.27M-3.09M-297.0K00
Research and development174.1M138.5M135.3M170.9M170.3M160.9M143.4M55.3M891.0K0
Selling, general and administrative37.6M36.1M38.5M47.6M45.8M49.7M39.1M44.1M262.0K83.0K
Operating income-170.7M-59.9M-183.8M-218.6M-216.1M-234.0M-186.1M-149.0M-6.65M-83.0K
Depreciation and amortization24.0K833.0K1.61M1.83M1.74M1.41M917.0K297.0K083.0K
EBITDA-170.7M-59.1M-182.2M-216.8M-214.4M-232.6M-185.2M-148.7M-6.65M0
Interest expense11.0M11.5M13.5M13.9M19.4M12.7M1.94M12.0K118.0K0
Income before tax-170.5M-55.6M-179.8M-229.4M-234.0M-243.4M-180.3M-147.0M6.77M-83.0K
Income tax-88.0K893.0K0015.1M8.22M000-83.0K
Net income-170.4M-56.5M-179.8M-229.4M-234.0M-243.4M-180.3M-147.0M-6.77M-83.0K
Earnings per share, basic-0.75-0.25-1.18-2.71-3.13-3.55-3.29-22.59-0.74-0.72
Earnings per share, diluted-0.75-0.25-1.18-2.71-3.13-3.55-3.29-22.59-0.74

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents37.7M46.1M32.1M112.0M183.4M486.1M135.0M105.2M315.0K60.0K
Short-term investments99.2M248.4M264.3M143.7M141.8M26.6M266.7M123.4M00
Receivables12.2M5.34M0200.0K200.0K1.50M500.0K
Inventory-136.0K365.0K-1.50M
Current assets167.6M309.9M306.5M261.9M331.8M522.3M409.3M232.0M445.0K60.0K
Property, plant and equipment64.0K10.0K1.65M3.98M5.32M5.53M5.42M3.19M
Total assets172.2M315.3M311.9M272.4M343.7M539.4M426.6M239.4M445.0K60.0K
Accounts payable5.96M2.32M5.53M1.46M3.24M7.51M956.0K2.18M97.0K40.0K
Current liabilities63.4M45.0M51.6M49.2M39.9M38.6M36.9M20.4M1.27M143.0K
Long-term debt198.5M0814.0K12.0M29.1M28.7M28.5M6.04M40.0K
Total debt202.9M012.4M23.6M29.1M28.7M28.5M6.04M40.0K
Total liabilities295.0M285.8M249.1M260.4M222.2M218.7M74.1M21.1M7.31M183.0K
Shareholders' equity-122.8M29.5M62.8M12.1M121.5M320.7M352.5M-120.1M-6.86M-123.0K
Shares outstanding2.92M226.6M225.4M94.4M75.8M73.9M61.6M8.05M75.5M114.5K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-171.3M-3.47M-159.2M-187.0M-188.9M-176.4M-144.8M-51.0M-5.75M20.0K
Capital spending-79.0K00-410.0K-1.55M-1.50M-2.97M-3.49M-3.49M-3.49M
Free cash flow-171.3M-3.47M-159.2M-187.4M-190.4M-177.9M-147.8M-54.5M-5.75M20.0K
Cash from investing156.4M29.0M-111.0M-1.03M-117.4M215.3M-147.1M-144.7M-144.7M-144.7M
Cash from financing6.42M-11.5M190.2M117.1M3.33M312.5M321.6M300.9M6.00M40.0K
Share buybacks629.0K444.0K122.9M3.33M117.6M293.4M303.0M
Change in cash-8.34M14.0M-79.9M-71.5M-303.2M351.5M29.7M105.1M255.0K0